Clinical Study
The Clinical Features and Prognosis of Gastric Remnant Carcinoma after Treatment
Table 2
Clinicopathological features of the 9 patients with gastric remnant carcinoma who survived for over 2 years.
| | No. | Gender | Age (years) | Interval (months) | TNM staging | Anastomotic site† | Comorbidity | Previous surgery | Prognosis (years) |
| | 1 | F | 71 | 30 | T1N3M0 | + | Total gastrectomy | Billroth II | >4 | | 2 | F | 52 | 20 | T1N0M0 | + | Total gastrectomy | Billroth II | >2 | | 3 | M | 63 | 40 | T1N0M0 | + | Total gastrectomy | Billroth I | >2 | | 4 | M | 72 | 16 | T1N0M0 | + | Total gastrectomy | Billroth II | >2 | | 5 | M | 73 | 20 | T1N1M0 | + | Total gastrectomy | Billroth II | >2 | | 6 | M | 67 | 32 | T1N1M0 | + | Chemotherapy | Billroth II | >2 | | 7 | F | 62 | 40 | T1N1M0 | + | Total gastrectomy | Billroth II | >2 | | 8 | M | 45 | 20 | T1N1M0 | + | Total gastrectomy | Billroth II | >2 | | 9 | M | 80 | 50 | T1N1M0 | + | Total gastrectomy | Billroth II | >3 |
|
|
†Abbreviation: TNM: tumor lymph node metastasis.
|
